Provided by Tiger Fintech (Singapore) Pte. Ltd.

Amneal Pharmaceuticals, Inc.

8.06
+0.06000.75%
Post-market: 8.150.0873+1.08%19:56 EDT
Volume:1.12M
Turnover:9.04M
Market Cap:2.53B
PE:-191.45
High:8.14
Open:8.00
Low:7.97
Close:8.00
Loading ...

Amneal Pharmaceuticals' Crexont Added to Three Insurance Coverage Accounts

MT Newswires Live
·
03 Apr

Amneal Pharmaceuticals announces expanded coverage for Crexont

TIPRANKS
·
03 Apr

BRIEF-Amneal Announces Expanded Coverage For Crexont® To Enhance Access For Parkinson’S Disease Patients In The U.S.

Reuters
·
03 Apr

Amneal Announces Expanded Coverage for CREXONT® (Carbidopa and Levodopa) to Enhance Access for Parkinson’s Disease Patients in the U.S.

Business Wire
·
03 Apr

BUZZ-India's Shilpa Medicare gains on launch of new version of cancer drug

Reuters
·
03 Apr

Amneal Pharmaceuticals announces U.S. launch of Boruzu

TIPRANKS
·
01 Apr

Amneal Launches BORUZU™, First Ready-to-Use Bortezomib Injection for Multiple Myeloma and Mantle Cell Lymphoma

Business Wire
·
01 Apr

Amneal Pharmaceuticals (AMRX) Stock Soars 45% on Success of New Parkinson’s Treatment

TIPRANKS
·
18 Mar

Amneal to Participate at Upcoming Investor Conference

Business Wire
·
11 Mar

Analysts Offer Insights on Healthcare Companies: Amneal Pharmaceuticals (AMRX), Sandoz Group Ltd (OtherSDZXF) and Medtronic (MDT)

TIPRANKS
·
10 Mar

Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers

StockStory
·
05 Mar

Amneal, mAbxience's Biologics Licensing Application for Denosumab Biosimilars Accepted for Review by FDA

MT Newswires Live
·
04 Mar

Amneal Pharmaceuticals BLA submissions for denosumab biosimilars accepted by FDA

TIPRANKS
·
04 Mar

BRIEF-Amneal’s BLA Submissions for Two Denosumab Biosimilars Accepted for Review by U.S. FDA

Reuters
·
04 Mar

Stock Track | Amneal Pharmaceuticals Soars 5.02% After Analysts Maintain Bullish Ratings

Stock Track
·
04 Mar

Truist Financial Sticks to Its Buy Rating for Amneal Pharmaceuticals (AMRX)

TIPRANKS
·
03 Mar

Amneal Pharmaceuticals Is Maintained at Overweight by Barclays

Dow Jones
·
03 Mar

Amneal Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.
·
01 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Recursion Pharmaceuticals, DoubleVerify Holdings, Praxis Precision Medicines

Reuters
·
28 Feb

Stock Track | Amneal Pharmaceuticals Plummets 6.09% in Friday Session, Weighed Down by Mixed Q4 Results and Weak Guidance

Stock Track
·
28 Feb